Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility

Zydus Lifesciences Limited has received the EIR report from the USFDA for the inspection conducted at the API Ahmedabad facility. The company had earlier received a Post Application Action Letter from the USFDA for the same inspection confirming that the inspected facility has been considered as ready to commercially manufacture and supply the API. This facility underwent an inspection from 14th to 22nd Dec 2023 and has been classified as Voluntary Action Indicated (VAI).

Rainbow Children's Medicare adds 50 bed additional block at Hydernagar, Hyderabad

Rainbow Children's Medicare Limited has added a ~50-bed additional block to the existing hospital at Hydernagar, Hyderabad, Telangana.

With this addition, the total bed capacity at Hydernagar Hospital will increase to ~160 beds. Consequently, the Company's overall bed capacity will increase to ~1,935 beds. This will further strengthen Company's Hub & Spoke network at Hyderabad, Telangana.